AURA
Price
$7.02
Change
+$0.07 (+1.01%)
Updated
Jun 23 closing price
Capitalization
725.26M
43 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$28.18
Change
+$0.95 (+3.49%)
Updated
Jun 23 closing price
Capitalization
3.54B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs RCUS

AURA vs RCUS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AURA vs. RCUS commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (AURA: $7.01 vs. RCUS: $28.18)
Brand notoriety: AURA and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 78% vs. RCUS: 121%
Market capitalization -- AURA: $725.26M vs. RCUS: $3.54B
AURA [@Biotechnology] is valued at $725.26M. RCUS’s [@Biotechnology] market capitalization is $3.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while RCUS’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 5 bearish.
  • RCUS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than RCUS.

Price Growth

AURA (@Biotechnology) experienced а +11.70% price change this week, while RCUS (@Biotechnology) price change was +19.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.83%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1945.11%.

Reported Earning Dates

AURA is expected to report earnings on Aug 06, 2026.

RCUS is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+5.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.54B) has a higher market cap than AURA($725M). AURA YTD gains are higher at: 28.716 vs. RCUS (18.254). AURA has higher annual earnings (EBITDA): -117.51M vs. RCUS (-350M). RCUS has more cash in the bank: 822M vs. AURA (115M). AURA has less debt than RCUS: AURA (17M) vs RCUS (113M). RCUS has higher revenues than AURA: RCUS (236M) vs AURA (0).
AURARCUSAURA / RCUS
Capitalization725M3.54B20%
EBITDA-117.51M-350M34%
Gain YTD28.71618.254157%
P/E RatioN/AN/A-
Revenue0236M-
Total Cash115M822M14%
Total Debt17M113M15%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURARCUS
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 21 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIGRX18.97N/A
N/A
Putnam International Value C
ICIEX24.61N/A
N/A
Nomura Core Equity Fund Class I
PGIIX20.39N/A
N/A
Polen Global Growth Institutional
MBERX32.88-0.01
-0.03%
NYLI Balanced Class R6
RNGEX85.75-2.96
-3.34%
American Funds New Economy R4

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+3.49%
XNCR - RCUS
52%
Loosely correlated
+0.50%
VIR - RCUS
50%
Loosely correlated
+6.01%
DYN - RCUS
46%
Loosely correlated
-3.02%
AURA - RCUS
45%
Loosely correlated
+0.94%
KURA - RCUS
45%
Loosely correlated
+0.19%
More